After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

Discover a recent study that revealed that patients treated for prostate cancer, particularly with radiotherapy, have an ...

At the heart of this discovery lies menadione, a precursor of vitamin K that has shown remarkable ability to target and ...

New London ― Dean Festa got lucky when he sought to make a change in his life insurance policy. His insurance agent told him ...

Opinion: The tiny tattoos of radiation therapy many cancer patients receive take an emotional toll — but they're increasingly ...

THURSDAY, Nov. 7, 2024 (HealthDay News) -- Men who undergo prostate cancer treatment face a greatly increased risk of ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...